N217S (p.Asn217Ser) variant of MED13L (Q71F56)

N217S (p.Asn217Ser) in MED13L (Q71F56) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.33 / 1. The record also includes population frequency data and structural context.

N217S (p.Asn217Ser) variant details